US Stock MarketDetailed Quotes

APRE Aprea Therapeutics

Watchlist
  • 5.084
  • -0.116-2.23%
Close Apr 29 16:00 ET
27.61MMarket Cap-1287P/E (TTM)

Aprea Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
51.31%-12.18M
6.99%-3.74M
65.99%-2.24M
63.87%-3.22M
45.79%-2.98M
33.63%-25.01M
60.50%-4.02M
19.93%-6.59M
-14.84%-8.9M
52.31%-5.5M
Net income from continuing operations
87.32%-14.29M
-40.99%-3.44M
20.38%-3.2M
96.68%-3.26M
44.81%-4.38M
-203.45%-112.66M
68.51%-2.44M
57.42%-4.02M
-858.52%-98.26M
17.91%-7.94M
Operating gains losses
113.83%38.93K
133.99%78.61K
111.83%2.88K
63.53%-56.36K
110.13%13.8K
11.30%-281.53K
147.88%33.6K
-211.17%-24.35K
-161.13%-154.57K
73.91%-136.21K
Depreciation and amortization
-96.22%7.05K
309.06%4.99K
-97.67%1.43K
-99.65%224
-99.36%410
-31.37%186.45K
-103.61%-2.39K
-11.63%61.37K
5.74%63.69K
-16.10%63.77K
Other non cash items
----
----
----
----
----
--72.52M
--0
--0
----
----
Change In working capital
192.05%1.62M
72.23%-462.86K
133.38%882.21K
-108.06%-170.99K
218.87%1.37M
78.88%-1.76M
63.04%-1.67M
-190.78%-2.64M
557.82%2.12M
113.31%429.75K
-Change in prepaid assets
-79.36%451.99K
35.98%-625.14K
-35.85%666.89K
-93.46%66.19K
-69.15%344.06K
2,103.04%2.19M
64.59%-976.42K
39.83%1.04M
3.97%1.01M
19.72%1.12M
-Change in payables and accrued expense
116.95%637.74K
46.59%-366.69K
105.97%215.32K
-120.49%-237.18K
264.10%1.03M
52.67%-3.76M
59.37%-686.5K
-127.89%-3.61M
296.06%1.16M
84.69%-625.41K
-Change in other current liabilities
--0
--0
--0
--0
--0
30.52%-186.7K
93.66%-4.01K
-8.47%-75.38K
21.44%-47.2K
20.76%-60.11K
-Change in other working capital
--528.97K
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
51.31%-12.18M
6.99%-3.74M
65.99%-2.24M
63.87%-3.22M
45.79%-2.98M
33.63%-25.01M
60.50%-4.02M
19.93%-6.59M
-14.84%-8.9M
52.31%-5.5M
Investing cash flow
Cash flow from continuing investing activities
-93.09K
-7.15K
0
0
Net PPE purchase and sale
---93.09K
---7.15K
----
----
----
--0
--0
----
----
----
Cash from discontinued investing activities
Investing cash flow
---93.09K
---7.15K
----
----
----
--0
--0
----
----
----
Financing cash flow
Cash flow from continuing financing activities
652.59%5.14M
0
0
0
5.14M
-60.91%682.97K
-94.06%98.53K
572.01%584.45K
0
0
Net common stock issuance
747.61%5.79M
--0
--0
--0
--5.79M
-55.61%682.97K
-93.60%98.53K
--584.45K
--0
--0
Proceeds from stock option exercised by employees
--0
----
----
----
----
--0
----
----
----
----
Net other financing activities
---648.93K
--0
--0
--0
---648.93K
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
652.59%5.14M
--0
--0
--0
--5.14M
-60.91%682.97K
-94.06%98.53K
572.01%584.45K
--0
--0
Net cash flow
Beginning cash position
-45.76%28.79M
-23.31%25.39M
-29.02%27.73M
-34.95%31M
-45.76%28.79M
-40.38%53.08M
-46.10%33.11M
-44.04%39.06M
-38.61%47.65M
-40.38%53.08M
Current changes in cash
70.69%-7.13M
4.47%-3.75M
61.25%-2.33M
63.87%-3.22M
139.32%2.16M
32.31%-24.33M
53.96%-3.92M
26.25%-6.01M
-14.84%-8.9M
52.31%-5.5M
Effect of exchange rate changes
-121.67%-8.4K
100.09%383
-105.89%-3.44K
-117.08%-53.5K
-32.22%48.16K
1,671.06%38.76K
-342.78%-403.97K
125.51%58.42K
619.10%313.25K
-41.03%71.05K
End cash Position
-24.80%21.65M
-24.80%21.65M
-23.31%25.39M
-29.02%27.73M
-34.95%31M
-45.76%28.79M
-45.76%28.79M
-46.10%33.11M
-44.04%39.06M
-38.61%47.65M
Free cash flow
50.94%-12.27M
6.81%-3.75M
64.69%-2.33M
63.87%-3.22M
45.79%-2.98M
33.63%-25.01M
60.50%-4.02M
19.93%-6.59M
-14.84%-8.9M
52.31%-5.5M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 51.31%-12.18M6.99%-3.74M65.99%-2.24M63.87%-3.22M45.79%-2.98M33.63%-25.01M60.50%-4.02M19.93%-6.59M-14.84%-8.9M52.31%-5.5M
Net income from continuing operations 87.32%-14.29M-40.99%-3.44M20.38%-3.2M96.68%-3.26M44.81%-4.38M-203.45%-112.66M68.51%-2.44M57.42%-4.02M-858.52%-98.26M17.91%-7.94M
Operating gains losses 113.83%38.93K133.99%78.61K111.83%2.88K63.53%-56.36K110.13%13.8K11.30%-281.53K147.88%33.6K-211.17%-24.35K-161.13%-154.57K73.91%-136.21K
Depreciation and amortization -96.22%7.05K309.06%4.99K-97.67%1.43K-99.65%224-99.36%410-31.37%186.45K-103.61%-2.39K-11.63%61.37K5.74%63.69K-16.10%63.77K
Other non cash items ----------------------72.52M--0--0--------
Change In working capital 192.05%1.62M72.23%-462.86K133.38%882.21K-108.06%-170.99K218.87%1.37M78.88%-1.76M63.04%-1.67M-190.78%-2.64M557.82%2.12M113.31%429.75K
-Change in prepaid assets -79.36%451.99K35.98%-625.14K-35.85%666.89K-93.46%66.19K-69.15%344.06K2,103.04%2.19M64.59%-976.42K39.83%1.04M3.97%1.01M19.72%1.12M
-Change in payables and accrued expense 116.95%637.74K46.59%-366.69K105.97%215.32K-120.49%-237.18K264.10%1.03M52.67%-3.76M59.37%-686.5K-127.89%-3.61M296.06%1.16M84.69%-625.41K
-Change in other current liabilities --0--0--0--0--030.52%-186.7K93.66%-4.01K-8.47%-75.38K21.44%-47.2K20.76%-60.11K
-Change in other working capital --528.97K------------------------------------
Cash from discontinued investing activities
Operating cash flow 51.31%-12.18M6.99%-3.74M65.99%-2.24M63.87%-3.22M45.79%-2.98M33.63%-25.01M60.50%-4.02M19.93%-6.59M-14.84%-8.9M52.31%-5.5M
Investing cash flow
Cash flow from continuing investing activities -93.09K-7.15K00
Net PPE purchase and sale ---93.09K---7.15K--------------0--0------------
Cash from discontinued investing activities
Investing cash flow ---93.09K---7.15K--------------0--0------------
Financing cash flow
Cash flow from continuing financing activities 652.59%5.14M0005.14M-60.91%682.97K-94.06%98.53K572.01%584.45K00
Net common stock issuance 747.61%5.79M--0--0--0--5.79M-55.61%682.97K-93.60%98.53K--584.45K--0--0
Proceeds from stock option exercised by employees --0------------------0----------------
Net other financing activities ---648.93K--0--0--0---648.93K--------------------
Cash from discontinued financing activities
Financing cash flow 652.59%5.14M--0--0--0--5.14M-60.91%682.97K-94.06%98.53K572.01%584.45K--0--0
Net cash flow
Beginning cash position -45.76%28.79M-23.31%25.39M-29.02%27.73M-34.95%31M-45.76%28.79M-40.38%53.08M-46.10%33.11M-44.04%39.06M-38.61%47.65M-40.38%53.08M
Current changes in cash 70.69%-7.13M4.47%-3.75M61.25%-2.33M63.87%-3.22M139.32%2.16M32.31%-24.33M53.96%-3.92M26.25%-6.01M-14.84%-8.9M52.31%-5.5M
Effect of exchange rate changes -121.67%-8.4K100.09%383-105.89%-3.44K-117.08%-53.5K-32.22%48.16K1,671.06%38.76K-342.78%-403.97K125.51%58.42K619.10%313.25K-41.03%71.05K
End cash Position -24.80%21.65M-24.80%21.65M-23.31%25.39M-29.02%27.73M-34.95%31M-45.76%28.79M-45.76%28.79M-46.10%33.11M-44.04%39.06M-38.61%47.65M
Free cash flow 50.94%-12.27M6.81%-3.75M64.69%-2.33M63.87%-3.22M45.79%-2.98M33.63%-25.01M60.50%-4.02M19.93%-6.59M-14.84%-8.9M52.31%-5.5M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg